Literature DB >> 11202988

Proniosomes: a novel drug carrier preparation.

C Hu1, D G Rhodes.   

Abstract

A procedure is described for producing a dry product which may be hydrated immediately before use to yield aqueous niosome dispersions similar to those produced by more cumbersome conventional methods. These 'proniosomes' minimize problems of niosome physical stability such as aggregation, fusion and leaking, and provide additional convenience in transportation, distribution, storage, and dosing. This report describes the preparation of dispersions of proniosome-derived niosomes, comparison of these niosomes to conventional niosomes, and optimization of proniosome formulations. In addition, conventional and proniosome-derived niosomes are compared in terms of their morphology, particle size, particle size distribution, and drug release performance in synthetic gastric or intestinal fluid. In all comparisons, proniosome-derived niosomes are as good or better than conventional niosomes.

Mesh:

Substances:

Year:  2000        PMID: 11202988

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.

Authors:  Angel Tan; Shasha Rao; Clive A Prestidge
Journal:  Pharm Res       Date:  2013-06-18       Impact factor: 4.200

2.  Development and optimization of novel controlled-release pioglitazone provesicular powders using 3² factorial design.

Authors:  Marwa H Shukr; Nadia A Eltablawy
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

3.  Penetration enhancers in proniosomes as a new strategy for enhanced transdermal drug delivery.

Authors:  Gamal M El Maghraby; Amal A Ahmed; Mohamed A Osman
Journal:  Saudi Pharm J       Date:  2014-05-12       Impact factor: 4.330

4.  Comparative study on the effects of some polyoxyethylene alkyl ether and sorbitan fatty acid ester surfactants on the performance of transdermal carvedilol proniosomal gel using experimental design.

Authors:  Ahmed A Aboelwafa; Doaa Ahmed El-Setouhy; Aliaa Nabil Elmeshad
Journal:  AAPS PharmSciTech       Date:  2010-11-10       Impact factor: 3.246

Review 5.  Gene Therapy: The Next-Generation Therapeutics and Their Delivery Approaches for Neurological Disorders.

Authors:  Abhik Paul; Michael G Collins; Hye Young Lee
Journal:  Front Genome Ed       Date:  2022-06-22

6.  Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies.

Authors:  Ghada A Abdelbary; Maha M Amin; Mohamed Y Zakaria
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.